Neubio
PrivateMomentum
Top 25%
of companies Caplight tracks
Company Overview
Neubio operates in Healthcare & Life Sciences and is based in Brügg. It was founded in 2019.
Neubio is a therapeutic devices company that develops and manufactures cochlear implant solutions for individuals with severe to profound hearing loss.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Patient Engagement
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neubio Comparables
Compare Neubio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TODOC | 83% | |
| Hemideina | 79% | |
| Nurotron Biotechnology Co., Ltd. | 76% |
For institutional investors. Book with your work email.
Neubio Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 903% MoM, from 69 to 692.
- May 1, 2025
Monthly visitors grew 74% MoM, reaching 440.
For institutional investors. Book with your work email.
Neubio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Neubio's valuation, stock price, and market status.
Is Neubio a public or private company?
Neubio is a private company.
What is the current stock price of Neubio?
Neubio is a private company, so its shares have no public market price. Caplight tracks Neubio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Neubio worth (valuation)?
Valuation information for Neubio is not publicly available.
Can I buy Neubio stock?
Neubio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Neubio's last funding round?
Funding round information for Neubio is not publicly available.
Who are the main investors in Neubio?
Investor information for Neubio is not publicly disclosed.
Will Neubio IPO soon?
No public IPO plans have been announced for Neubio.
How can I track Neubio secondary market activity?
Caplight tracks bids, offers, and trades in Neubio's shares on secondary markets.